These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1731112)

  • 21. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).
    Reitz MS; Hall L; Robert-Guroff M; Lautenberger J; Hahn BM; Shaw GM; Kong LI; Weiss SH; Waters D; Gallo RC
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1143-55. PubMed ID: 7826699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.
    Ball JK; Holmes EC; Whitwell H; Desselberger U
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():67-79. PubMed ID: 8151287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.
    Shugars DC; Smith MS; Glueck DH; Nantermet PV; Seillier-Moiseiwitsch F; Swanstrom R
    J Virol; 1993 Aug; 67(8):4639-50. PubMed ID: 8043040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data.
    Bobkov A; Garaev MM; Rzhaninova A; Kaleebu P; Pitman R; Weber JN; Cheingsong-Popov R
    AIDS; 1994 May; 8(5):619-24. PubMed ID: 8060542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
    Gómez Carrillo M; Piccardo C; Libonatti O
    Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.
    Kuiken CL; Zwart G; Baan E; Coutinho RA; van den Hoek JA; Goudsmit J
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9061-5. PubMed ID: 8415653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
    Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
    J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
    Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J
    J Virol; 1992 Jul; 66(7):4622-7. PubMed ID: 1602564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo genetic variability of the human immunodeficiency virus type 2 V3 region.
    Boeri E; Giri A; Lillo F; Ferrari G; Varnier OE; Ferro A; Sabbatani S; Saxinger WC; Franchini G
    J Virol; 1992 Jul; 66(7):4546-50. PubMed ID: 1602560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy.
    van't Wout AB; Ran LJ; Kuiken CL; Kootstra NA; Pals ST; Schuitemaker H
    J Virol; 1998 Jan; 72(1):488-96. PubMed ID: 9420250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants.
    Jameel S; Zafrullah M; Ahmad M; Kapoor GS; Sehgal S
    AIDS; 1995 Jul; 9(7):685-90. PubMed ID: 7546411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of baboons with simian/human immunodeficiency viruses.
    Allan JS; Ray P; Broussard S; Whitehead E; Hubbard G; Butler T; Brasky K; Luciw P; Cheng-Mayer C; Levy JA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):429-41. PubMed ID: 7627620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
    Li Y; Hui H; Burgess CJ; Price RW; Sharp PM; Hahn BH; Shaw GM
    J Virol; 1992 Nov; 66(11):6587-600. PubMed ID: 1404605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of the human immunodeficiency virus type 1 envelope glycoprotein in San Francisco Men's Health Study participants.
    McCutchan FE; Sanders-Buell E; Salminen MO; Carr JK; Sheppard WH
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):329-37. PubMed ID: 9519894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.
    Daniels RS; Smith MH; Fisher AG
    J Virol; 1991 Oct; 65(10):5574-8. PubMed ID: 1895406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular subtypes of env sequences around V3 region of human immunodeficiency virus type 1 in Taiwan.
    Chang KS; Lin CI; Ling P; Lin KH; Lin HC; Twu SJ
    Eur J Epidemiol; 1994 Jun; 10(3):247-50. PubMed ID: 7859833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.
    Shioda T; Oka S; Ida S; Nokihara K; Toriyoshi H; Mori S; Takebe Y; Kimura S; Shimada K; Nagai Y
    J Virol; 1994 Dec; 68(12):7689-96. PubMed ID: 7966558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.
    Zhang LQ; MacKenzie P; Cleland A; Holmes EC; Brown AJ; Simmonds P
    J Virol; 1993 Jun; 67(6):3345-56. PubMed ID: 8497055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a quasispecies of human immunodeficiency virus type 1 in vivo.
    Cichutek K; Merget H; Norley S; Linde R; Kreuz W; Gahr M; Kurth R
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7365-9. PubMed ID: 1502146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.